Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Experimental Cell Research
|
June 12, 2020
The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3β pathway in prostate cancer
Juanhua Tian, Haibao Zhang, Lijun Mu, et al.
International Journal of Oncology
|
October 27, 2015
Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling
Yuefeng Du, Qingzhi Long, Lin Zhang, et al.
Oncology Reports
|
September 9, 2020
MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2
Lijun Mu, Bing Guan, Juanhua Tian, et al.
Oncology Reports
|
September 14, 2022
[Corrigendum] MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2
Lijun Mu, Bing Guan, Juanhua Tian, et al.
Reproductive Biology
|
July 27, 2023
Cell apoptosis in the testis of male rats is elevated by intervention with β-endorphin and the mu opioid receptor
Xiaofan Xiong, Siyu Zhang, Lulu Zang, et al.
Cancer Letters
|
November 19, 2015
Non-canonical GLI1/2 activation by PI3K/AKT signaling in renal cell carcinoma: A novel potential therapeutic target
Jiancheng Zhou, Guodong Zhu, Jun Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 6, 2025
Norepinephrine Induces Sertoli Cell Ferroptosis via Receptors Desensitization Causing Stress-Related Male Reproductive Dysfunction
Lingyu Zhang, Shanfeng Gao, Xiaofan Xiong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 27, 2020
Macroscale Superlubricity Enabled by Graphene-Coated Surfaces
Zhenyu Zhang, Yuefeng Du, Siling Huang, et al.
Oncotarget
|
December 29, 2016
Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer
Bing Guan, Kaijie Wu, Jin Zeng, et al.
Oncotarget
|
March 14, 2022
Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer
Bing Guan, Kaijie Wu, Jin Zeng, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Experimental Cell Research
|
June 12, 2020
The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3β pathway in prostate cancer
Juanhua Tian, Haibao Zhang, Lijun Mu, et al.
International Journal of Oncology
|
October 27, 2015
Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling
Yuefeng Du, Qingzhi Long, Lin Zhang, et al.
Oncology Reports
|
September 9, 2020
MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2
Lijun Mu, Bing Guan, Juanhua Tian, et al.
Oncology Reports
|
September 14, 2022
[Corrigendum] MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2
Lijun Mu, Bing Guan, Juanhua Tian, et al.
Reproductive Biology
|
July 27, 2023
Cell apoptosis in the testis of male rats is elevated by intervention with β-endorphin and the mu opioid receptor
Xiaofan Xiong, Siyu Zhang, Lulu Zang, et al.
Cancer Letters
|
November 19, 2015
Non-canonical GLI1/2 activation by PI3K/AKT signaling in renal cell carcinoma: A novel potential therapeutic target
Jiancheng Zhou, Guodong Zhu, Jun Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 6, 2025
Norepinephrine Induces Sertoli Cell Ferroptosis via Receptors Desensitization Causing Stress-Related Male Reproductive Dysfunction
Lingyu Zhang, Shanfeng Gao, Xiaofan Xiong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 27, 2020
Macroscale Superlubricity Enabled by Graphene-Coated Surfaces
Zhenyu Zhang, Yuefeng Du, Siling Huang, et al.
Oncotarget
|
December 29, 2016
Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer
Bing Guan, Kaijie Wu, Jin Zeng, et al.
Oncotarget
|
March 14, 2022
Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer
Bing Guan, Kaijie Wu, Jin Zeng, et al.
Page
of 4